SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
Sequencing Quality Control Phase 2 (SEQC2)
|
Resource Development
|
FDA
|
NLM, CIT, NCI, NHLBI, NIEHS
|
2017
|
|
Sudden Death in the Young (SDY) Registry
|
Resource Development
|
CDC, HRSA
|
NHLBI, NINDS
|
2013
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, IOS, ASPR
|
OD/ OSP
|
2013
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
|
1973
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
|
2003
|
|